Drug · DIN 02432552
VAN-GABAPENTIN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 7, 2019; first marketed July 7, 2015.
- Drug Identification Number (DIN)
- 02432552
- Company (DIN owner)
- Vanc Pharmaceuticals IncRichmond, British Columbia, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Gabapentin N02BF01
- Class
- Human
- Record last updated
- June 24, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GABAPENTIN | 800 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 14, 2014: NOC 16285Abbreviated New Drug Submission (ANDS) · Licensing agreement between two companies
Other DINs named VAN-GABAPENTIN
- DIN 02431408 · Cancelled Post Market
- DIN 02431416 · Cancelled Post Market
- DIN 02431424 · Cancelled Post Market
- DIN 02432544 · Cancelled Post Market